{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morgantown",
      "state": "WV",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89970",
      "recalling_firm": "Mylan Pharmaceuticals Inc",
      "address_1": "3711 Collins Ferry Rd",
      "address_2": "",
      "postal_code": "26505-2362",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "USA nationwide.",
      "recall_number": "D-0845-2022",
      "product_description": "Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80",
      "product_quantity": "89,665 vials",
      "reason_for_recall": "Labeling: Missing label on the vial",
      "recall_initiation_date": "20220412",
      "center_classification_date": "20220504",
      "termination_date": "20231018",
      "report_date": "20220504",
      "code_info": "Lot #: BF21002800, Exp 8/2023",
      "more_code_info": ""
    }
  ]
}